These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2157977)
1. Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytes. Glick AB; Danielpour D; Morgan D; Sporn MB; Yuspa SH Mol Endocrinol; 1990 Jan; 4(1):46-52. PubMed ID: 2157977 [TBL] [Abstract][Full Text] [Related]
2. Selective changes in laminin adhesion and alpha 6 beta 4 integrin regulation are associated with the initial steps in keratinocyte maturation. Tennenbaum T; Li L; Belanger AJ; De Luca LM; Yuspa SH Cell Growth Differ; 1996 May; 7(5):615-28. PubMed ID: 8732671 [TBL] [Abstract][Full Text] [Related]
3. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta. Matsumoto K; Hashimoto K; Hashiro M; Yoshimasa H; Yoshikawa K J Cell Physiol; 1990 Oct; 145(1):95-101. PubMed ID: 2211846 [TBL] [Abstract][Full Text] [Related]
4. Further studies of the role of transforming growth factor-beta in human B cell function. Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Piazza GA; Ritter JL; Baracka CA Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633 [TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines. Hébert CD; Birnbaum LS Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899 [TBL] [Abstract][Full Text] [Related]
8. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression. Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000 [TBL] [Abstract][Full Text] [Related]
9. Differential binding of transforming growth factor-beta 1, -beta 2, and -beta 3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors. Lyons RM; Miller DA; Graycar JL; Moses HL; Derynck R Mol Endocrinol; 1991 Dec; 5(12):1887-96. PubMed ID: 1665203 [TBL] [Abstract][Full Text] [Related]
10. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Bascom CC; Wolfshohl JR; Coffey RJ; Madisen L; Webb NR; Purchio AR; Derynck R; Moses HL Mol Cell Biol; 1989 Dec; 9(12):5508-15. PubMed ID: 2586525 [TBL] [Abstract][Full Text] [Related]
11. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis. Werner S; Beer HD; Mauch C; Lüscher B; Werner S Oncogene; 2001 Nov; 20(51):7494-504. PubMed ID: 11709721 [TBL] [Abstract][Full Text] [Related]
12. Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of epidermal cell proliferation. Richter KH; Schnapke R; Clauss M; Fürstenberger G; Hinz D; Marks F J Cell Physiol; 1990 Mar; 142(3):496-504. PubMed ID: 1968903 [TBL] [Abstract][Full Text] [Related]
13. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756 [TBL] [Abstract][Full Text] [Related]